Global Recombinant Vaccines Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
Recombinant or purified protein vaccines consist of protein antigens that have either been produced in a heterologous expression system (e.g., bacteria or yeast) or purified from large amounts of the pathogenic organism. The vaccinated person produces antibodies to the protein antigen, thus protecting him/her from disease.
Recombinant/purified protein vaccines are based on the concept that humoral immune responses mounted to an infection are often targeted toward specific localized regions on the surface of protein antigens known as epitopes. The recombinant proteins for vaccination are produced by expressing these immunogenic proteins using heterologous expression systems. The immunogenic protein antigens can also be purified from the infectious organism. Once purified, protein antigens, recombinant and endogenous, are administered with an adjuvant to boost the immune response. Administering just the most immunogenic protein or proteins from an infectious organisms as a vaccine produces a more targeted immune response. This strategy also eliminates the risk of active infection that can occur with live attenuated vaccines or even inactivated vaccines where inactivation is incomplete.
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Recombinant Vaccines market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Recombinant Vaccines market are covered in Chapter 9:
Green Cross Corporation
Bayer AG
Mitsubishi Tanabe Pharma Corporation
Pfizer, Inc.
GlaxoSmithKline
Protein Science Corporation
Merck & Co., Inc
Sanofi Pasteur SA
Daiichi Sankyo
Serum Institute of India Pvt. Ltd
Pfizer Inc.
Abiomed
Emergent Bio Solutions, Inc.
Johnson & Johnson
In Chapter 5 and Chapter 7.3, based on types, the Recombinant Vaccines market from 2017 to 2027 is primarily split into:
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
In Chapter 6 and Chapter 7.4, based on applications, the Recombinant Vaccines market from 2017 to 2027 covers:
Recombinant Human Vaccines
Animal Recombinant Vaccines
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Recombinant Vaccines market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Recombinant Vaccines Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 RECOMBINANT VACCINES MARKET OVERVIEW
1.1 Product Overview and Scope of Recombinant Vaccines Market
1.2 Recombinant Vaccines Market Segment by Type
1.2.1 Global Recombinant Vaccines Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Recombinant Vaccines Market Segment by Application
1.3.1 Recombinant Vaccines Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Recombinant Vaccines Market, Region Wise (2017-2027)
1.4.1 Global Recombinant Vaccines Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Recombinant Vaccines Market Status and Prospect (2017-2027)
1.4.3 Europe Recombinant Vaccines Market Status and Prospect (2017-2027)
1.4.4 China Recombinant Vaccines Market Status and Prospect (2017-2027)
1.4.5 Japan Recombinant Vaccines Market Status and Prospect (2017-2027)
1.4.6 India Recombinant Vaccines Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Recombinant Vaccines Market Status and Prospect (2017-2027)
1.4.8 Latin America Recombinant Vaccines Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Recombinant Vaccines Market Status and Prospect (2017-2027)
1.5 Global Market Size of Recombinant Vaccines (2017-2027)
1.5.1 Global Recombinant Vaccines Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Recombinant Vaccines Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Recombinant Vaccines Market
2 INDUSTRY OUTLOOK
2.1 Recombinant Vaccines Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Recombinant Vaccines Market Drivers Analysis
2.4 Recombinant Vaccines Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Recombinant Vaccines Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Recombinant Vaccines Industry Development
3 GLOBAL RECOMBINANT VACCINES MARKET LANDSCAPE BY PLAYER
3.1 Global Recombinant Vaccines Sales Volume and Share by Player (2017-2022)
3.2 Global Recombinant Vaccines Revenue and Market Share by Player (2017-2022)
3.3 Global Recombinant Vaccines Average Price by Player (2017-2022)
3.4 Global Recombinant Vaccines Gross Margin by Player (2017-2022)
3.5 Recombinant Vaccines Market Competitive Situation and Trends
3.5.1 Recombinant Vaccines Market Concentration Rate
3.5.2 Recombinant Vaccines Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL RECOMBINANT VACCINES SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Recombinant Vaccines Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Recombinant Vaccines Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Recombinant Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Recombinant Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Recombinant Vaccines Market Under COVID-19
4.5 Europe Recombinant Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Recombinant Vaccines Market Under COVID-19
4.6 China Recombinant Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Recombinant Vaccines Market Under COVID-19
4.7 Japan Recombinant Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Recombinant Vaccines Market Under COVID-19
4.8 India Recombinant Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Recombinant Vaccines Market Under COVID-19
4.9 Southeast Asia Recombinant Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Recombinant Vaccines Market Under COVID-19
4.10 Latin America Recombinant Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Recombinant Vaccines Market Under COVID-19
4.11 Middle East and Africa Recombinant Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Recombinant Vaccines Market Under COVID-19
5 GLOBAL RECOMBINANT VACCINES SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Recombinant Vaccines Sales Volume and Market Share by Type (2017-2022)
5.2 Global Recombinant Vaccines Revenue and Market Share by Type (2017-2022)
5.3 Global Recombinant Vaccines Price by Type (2017-2022)
5.4 Global Recombinant Vaccines Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Recombinant Vaccines Sales Volume, Revenue and Growth Rate of Subunit Recombinant Vaccines (2017-2022)
5.4.2 Global Recombinant Vaccines Sales Volume, Revenue and Growth Rate of Attenuated Recombinant Vaccines (2017-2022)
5.4.3 Global Recombinant Vaccines Sales Volume, Revenue and Growth Rate of Vector Recombinant Vaccines (2017-2022)
6 GLOBAL RECOMBINANT VACCINES MARKET ANALYSIS BY APPLICATION
6.1 Global Recombinant Vaccines Consumption and Market Share by Application (2017-2022)
6.2 Global Recombinant Vaccines Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Recombinant Vaccines Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Recombinant Vaccines Consumption and Growth Rate of Recombinant Human Vaccines (2017-2022)
6.3.2 Global Recombinant Vaccines Consumption and Growth Rate of Animal Recombinant Vaccines (2017-2022)
7 GLOBAL RECOMBINANT VACCINES MARKET FORECAST (2022-2027)
7.1 Global Recombinant Vaccines Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Recombinant Vaccines Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Recombinant Vaccines Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Recombinant Vaccines Price and Trend Forecast (2022-2027)
7.2 Global Recombinant Vaccines Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Recombinant Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Recombinant Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Recombinant Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Recombinant Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Recombinant Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Recombinant Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Recombinant Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Recombinant Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Recombinant Vaccines Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Recombinant Vaccines Revenue and Growth Rate of Subunit Recombinant Vaccines (2022-2027)
7.3.2 Global Recombinant Vaccines Revenue and Growth Rate of Attenuated Recombinant Vaccines (2022-2027)
7.3.3 Global Recombinant Vaccines Revenue and Growth Rate of Vector Recombinant Vaccines (2022-2027)
7.4 Global Recombinant Vaccines Consumption Forecast by Application (2022-2027)
7.4.1 Global Recombinant Vaccines Consumption Value and Growth Rate of Recombinant Human Vaccines(2022-2027)
7.4.2 Global Recombinant Vaccines Consumption Value and Growth Rate of Animal Recombinant Vaccines(2022-2027)
7.5 Recombinant Vaccines Market Forecast Under COVID-19
8 RECOMBINANT VACCINES MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Recombinant Vaccines Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Recombinant Vaccines Analysis
8.6 Major Downstream Buyers of Recombinant Vaccines Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Recombinant Vaccines Industry
9 PLAYERS PROFILES
9.1 Green Cross Corporation
9.1.1 Green Cross Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Recombinant Vaccines Product Profiles, Application and Specification
9.1.3 Green Cross Corporation Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Bayer AG
9.2.1 Bayer AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Recombinant Vaccines Product Profiles, Application and Specification
9.2.3 Bayer AG Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Mitsubishi Tanabe Pharma Corporation
9.3.1 Mitsubishi Tanabe Pharma Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Recombinant Vaccines Product Profiles, Application and Specification
9.3.3 Mitsubishi Tanabe Pharma Corporation Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Pfizer, Inc.
9.4.1 Pfizer, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Recombinant Vaccines Product Profiles, Application and Specification
9.4.3 Pfizer, Inc. Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 GlaxoSmithKline
9.5.1 GlaxoSmithKline Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Recombinant Vaccines Product Profiles, Application and Specification
9.5.3 GlaxoSmithKline Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Protein Science Corporation
9.6.1 Protein Science Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Recombinant Vaccines Product Profiles, Application and Specification
9.6.3 Protein Science Corporation Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Merck & Co., Inc
9.7.1 Merck & Co., Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Recombinant Vaccines Product Profiles, Application and Specification
9.7.3 Merck & Co., Inc Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Sanofi Pasteur SA
9.8.1 Sanofi Pasteur SA Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Recombinant Vaccines Product Profiles, Application and Specification
9.8.3 Sanofi Pasteur SA Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Daiichi Sankyo
9.9.1 Daiichi Sankyo Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Recombinant Vaccines Product Profiles, Application and Specification
9.9.3 Daiichi Sankyo Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Serum Institute of India Pvt. Ltd
9.10.1 Serum Institute of India Pvt. Ltd Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Recombinant Vaccines Product Profiles, Application and Specification
9.10.3 Serum Institute of India Pvt. Ltd Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Pfizer Inc.
9.11.1 Pfizer Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Recombinant Vaccines Product Profiles, Application and Specification
9.11.3 Pfizer Inc. Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Abiomed
9.12.1 Abiomed Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Recombinant Vaccines Product Profiles, Application and Specification
9.12.3 Abiomed Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Emergent Bio Solutions, Inc.
9.13.1 Emergent Bio Solutions, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Recombinant Vaccines Product Profiles, Application and Specification
9.13.3 Emergent Bio Solutions, Inc. Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Johnson & Johnson
9.14.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Recombinant Vaccines Product Profiles, Application and Specification
9.14.3 Johnson & Johnson Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Recombinant Vaccines Market
1.2 Recombinant Vaccines Market Segment by Type
1.2.1 Global Recombinant Vaccines Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Recombinant Vaccines Market Segment by Application
1.3.1 Recombinant Vaccines Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Recombinant Vaccines Market, Region Wise (2017-2027)
1.4.1 Global Recombinant Vaccines Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Recombinant Vaccines Market Status and Prospect (2017-2027)
1.4.3 Europe Recombinant Vaccines Market Status and Prospect (2017-2027)
1.4.4 China Recombinant Vaccines Market Status and Prospect (2017-2027)
1.4.5 Japan Recombinant Vaccines Market Status and Prospect (2017-2027)
1.4.6 India Recombinant Vaccines Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Recombinant Vaccines Market Status and Prospect (2017-2027)
1.4.8 Latin America Recombinant Vaccines Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Recombinant Vaccines Market Status and Prospect (2017-2027)
1.5 Global Market Size of Recombinant Vaccines (2017-2027)
1.5.1 Global Recombinant Vaccines Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Recombinant Vaccines Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Recombinant Vaccines Market
2 INDUSTRY OUTLOOK
2.1 Recombinant Vaccines Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Recombinant Vaccines Market Drivers Analysis
2.4 Recombinant Vaccines Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Recombinant Vaccines Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Recombinant Vaccines Industry Development
3 GLOBAL RECOMBINANT VACCINES MARKET LANDSCAPE BY PLAYER
3.1 Global Recombinant Vaccines Sales Volume and Share by Player (2017-2022)
3.2 Global Recombinant Vaccines Revenue and Market Share by Player (2017-2022)
3.3 Global Recombinant Vaccines Average Price by Player (2017-2022)
3.4 Global Recombinant Vaccines Gross Margin by Player (2017-2022)
3.5 Recombinant Vaccines Market Competitive Situation and Trends
3.5.1 Recombinant Vaccines Market Concentration Rate
3.5.2 Recombinant Vaccines Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL RECOMBINANT VACCINES SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Recombinant Vaccines Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Recombinant Vaccines Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Recombinant Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Recombinant Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Recombinant Vaccines Market Under COVID-19
4.5 Europe Recombinant Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Recombinant Vaccines Market Under COVID-19
4.6 China Recombinant Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Recombinant Vaccines Market Under COVID-19
4.7 Japan Recombinant Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Recombinant Vaccines Market Under COVID-19
4.8 India Recombinant Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Recombinant Vaccines Market Under COVID-19
4.9 Southeast Asia Recombinant Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Recombinant Vaccines Market Under COVID-19
4.10 Latin America Recombinant Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Recombinant Vaccines Market Under COVID-19
4.11 Middle East and Africa Recombinant Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Recombinant Vaccines Market Under COVID-19
5 GLOBAL RECOMBINANT VACCINES SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Recombinant Vaccines Sales Volume and Market Share by Type (2017-2022)
5.2 Global Recombinant Vaccines Revenue and Market Share by Type (2017-2022)
5.3 Global Recombinant Vaccines Price by Type (2017-2022)
5.4 Global Recombinant Vaccines Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Recombinant Vaccines Sales Volume, Revenue and Growth Rate of Subunit Recombinant Vaccines (2017-2022)
5.4.2 Global Recombinant Vaccines Sales Volume, Revenue and Growth Rate of Attenuated Recombinant Vaccines (2017-2022)
5.4.3 Global Recombinant Vaccines Sales Volume, Revenue and Growth Rate of Vector Recombinant Vaccines (2017-2022)
6 GLOBAL RECOMBINANT VACCINES MARKET ANALYSIS BY APPLICATION
6.1 Global Recombinant Vaccines Consumption and Market Share by Application (2017-2022)
6.2 Global Recombinant Vaccines Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Recombinant Vaccines Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Recombinant Vaccines Consumption and Growth Rate of Recombinant Human Vaccines (2017-2022)
6.3.2 Global Recombinant Vaccines Consumption and Growth Rate of Animal Recombinant Vaccines (2017-2022)
7 GLOBAL RECOMBINANT VACCINES MARKET FORECAST (2022-2027)
7.1 Global Recombinant Vaccines Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Recombinant Vaccines Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Recombinant Vaccines Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Recombinant Vaccines Price and Trend Forecast (2022-2027)
7.2 Global Recombinant Vaccines Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Recombinant Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Recombinant Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Recombinant Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Recombinant Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Recombinant Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Recombinant Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Recombinant Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Recombinant Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Recombinant Vaccines Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Recombinant Vaccines Revenue and Growth Rate of Subunit Recombinant Vaccines (2022-2027)
7.3.2 Global Recombinant Vaccines Revenue and Growth Rate of Attenuated Recombinant Vaccines (2022-2027)
7.3.3 Global Recombinant Vaccines Revenue and Growth Rate of Vector Recombinant Vaccines (2022-2027)
7.4 Global Recombinant Vaccines Consumption Forecast by Application (2022-2027)
7.4.1 Global Recombinant Vaccines Consumption Value and Growth Rate of Recombinant Human Vaccines(2022-2027)
7.4.2 Global Recombinant Vaccines Consumption Value and Growth Rate of Animal Recombinant Vaccines(2022-2027)
7.5 Recombinant Vaccines Market Forecast Under COVID-19
8 RECOMBINANT VACCINES MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Recombinant Vaccines Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Recombinant Vaccines Analysis
8.6 Major Downstream Buyers of Recombinant Vaccines Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Recombinant Vaccines Industry
9 PLAYERS PROFILES
9.1 Green Cross Corporation
9.1.1 Green Cross Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Recombinant Vaccines Product Profiles, Application and Specification
9.1.3 Green Cross Corporation Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Bayer AG
9.2.1 Bayer AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Recombinant Vaccines Product Profiles, Application and Specification
9.2.3 Bayer AG Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Mitsubishi Tanabe Pharma Corporation
9.3.1 Mitsubishi Tanabe Pharma Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Recombinant Vaccines Product Profiles, Application and Specification
9.3.3 Mitsubishi Tanabe Pharma Corporation Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Pfizer, Inc.
9.4.1 Pfizer, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Recombinant Vaccines Product Profiles, Application and Specification
9.4.3 Pfizer, Inc. Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 GlaxoSmithKline
9.5.1 GlaxoSmithKline Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Recombinant Vaccines Product Profiles, Application and Specification
9.5.3 GlaxoSmithKline Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Protein Science Corporation
9.6.1 Protein Science Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Recombinant Vaccines Product Profiles, Application and Specification
9.6.3 Protein Science Corporation Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Merck & Co., Inc
9.7.1 Merck & Co., Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Recombinant Vaccines Product Profiles, Application and Specification
9.7.3 Merck & Co., Inc Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Sanofi Pasteur SA
9.8.1 Sanofi Pasteur SA Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Recombinant Vaccines Product Profiles, Application and Specification
9.8.3 Sanofi Pasteur SA Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Daiichi Sankyo
9.9.1 Daiichi Sankyo Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Recombinant Vaccines Product Profiles, Application and Specification
9.9.3 Daiichi Sankyo Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Serum Institute of India Pvt. Ltd
9.10.1 Serum Institute of India Pvt. Ltd Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Recombinant Vaccines Product Profiles, Application and Specification
9.10.3 Serum Institute of India Pvt. Ltd Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Pfizer Inc.
9.11.1 Pfizer Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Recombinant Vaccines Product Profiles, Application and Specification
9.11.3 Pfizer Inc. Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Abiomed
9.12.1 Abiomed Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Recombinant Vaccines Product Profiles, Application and Specification
9.12.3 Abiomed Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Emergent Bio Solutions, Inc.
9.13.1 Emergent Bio Solutions, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Recombinant Vaccines Product Profiles, Application and Specification
9.13.3 Emergent Bio Solutions, Inc. Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Johnson & Johnson
9.14.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Recombinant Vaccines Product Profiles, Application and Specification
9.14.3 Johnson & Johnson Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Recombinant Vaccines Product Picture
Table Global Recombinant Vaccines Market Sales Volume and CAGR (%) Comparison by Type
Table Recombinant Vaccines Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Recombinant Vaccines Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Recombinant Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Recombinant Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Recombinant Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Recombinant Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Recombinant Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Recombinant Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Recombinant Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Recombinant Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Recombinant Vaccines Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Recombinant Vaccines Industry Development
Table Global Recombinant Vaccines Sales Volume by Player (2017-2022)
Table Global Recombinant Vaccines Sales Volume Share by Player (2017-2022)
Figure Global Recombinant Vaccines Sales Volume Share by Player in 2021
Table Recombinant Vaccines Revenue (Million USD) by Player (2017-2022)
Table Recombinant Vaccines Revenue Market Share by Player (2017-2022)
Table Recombinant Vaccines Price by Player (2017-2022)
Table Recombinant Vaccines Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Recombinant Vaccines Sales Volume, Region Wise (2017-2022)
Table Global Recombinant Vaccines Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Recombinant Vaccines Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Recombinant Vaccines Sales Volume Market Share, Region Wise in 2021
Table Global Recombinant Vaccines Revenue (Million USD), Region Wise (2017-2022)
Table Global Recombinant Vaccines Revenue Market Share, Region Wise (2017-2022)
Figure Global Recombinant Vaccines Revenue Market Share, Region Wise (2017-2022)
Figure Global Recombinant Vaccines Revenue Market Share, Region Wise in 2021
Table Global Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Recombinant Vaccines Sales Volume by Type (2017-2022)
Table Global Recombinant Vaccines Sales Volume Market Share by Type (2017-2022)
Figure Global Recombinant Vaccines Sales Volume Market Share by Type in 2021
Table Global Recombinant Vaccines Revenue (Million USD) by Type (2017-2022)
Table Global Recombinant Vaccines Revenue Market Share by Type (2017-2022)
Figure Global Recombinant Vaccines Revenue Market Share by Type in 2021
Table Recombinant Vaccines Price by Type (2017-2022)
Figure Global Recombinant Vaccines Sales Volume and Growth Rate of Subunit Recombinant Vaccines (2017-2022)
Figure Global Recombinant Vaccines Revenue (Million USD) and Growth Rate of Subunit Recombinant Vaccines (2017-2022)
Figure Global Recombinant Vaccines Sales Volume and Growth Rate of Attenuated Recombinant Vaccines (2017-2022)
Figure Global Recombinant Vaccines Revenue (Million USD) and Growth Rate of Attenuated Recombinant Vaccines (2017-2022)
Figure Global Recombinant Vaccines Sales Volume and Growth Rate of Vector Recombinant Vaccines (2017-2022)
Figure Global Recombinant Vaccines Revenue (Million USD) and Growth Rate of Vector Recombinant Vaccines (2017-2022)
Table Global Recombinant Vaccines Consumption by Application (2017-2022)
Table Global Recombinant Vaccines Consumption Market Share by Application (2017-2022)
Table Global Recombinant Vaccines Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Recombinant Vaccines Consumption Revenue Market Share by Application (2017-2022)
Table Global Recombinant Vaccines Consumption and Growth Rate of Recombinant Human Vaccines (2017-2022)
Table Global Recombinant Vaccines Consumption and Growth Rate of Animal Recombinant Vaccines (2017-2022)
Figure Global Recombinant Vaccines Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Recombinant Vaccines Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Recombinant Vaccines Price and Trend Forecast (2022-2027)
Figure USA Recombinant Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Recombinant Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Recombinant Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Recombinant Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Recombinant Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Recombinant Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Recombinant Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Recombinant Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Recombinant Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Recombinant Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Recombinant Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Recombinant Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Recombinant Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Recombinant Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Recombinant Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Recombinant Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Recombinant Vaccines Market Sales Volume Forecast, by Type
Table Global Recombinant Vaccines Sales Volume Market Share Forecast, by Type
Table Global Recombinant Vaccines Market Revenue (Million USD) Forecast, by Type
Table Global Recombinant Vaccines Revenue Market Share Forecast, by Type
Table Global Recombinant Vaccines Price Forecast, by Type
Figure Global Recombinant Vaccines Revenue (Million USD) and Growth Rate of Subunit Recombinant Vaccines (2022-2027)
Figure Global Recombinant Vaccines Revenue (Million USD) and Growth Rate of Subunit Recombinant Vaccines (2022-2027)
Figure Global Recombinant Vaccines Revenue (Million USD) and Growth Rate of Attenuated Recombinant Vaccines (2022-2027)
Figure Global Recombinant Vaccines Revenue (Million USD) and Growth Rate of Attenuated Recombinant Vaccines (2022-2027)
Figure Global Recombinant Vaccines Revenue (Million USD) and Growth Rate of Vector Recombinant Vaccines (2022-2027)
Figure Global Recombinant Vaccines Revenue (Million USD) and Growth Rate of Vector Recombinant Vaccines (2022-2027)
Table Global Recombinant Vaccines Market Consumption Forecast, by Application
Table Global Recombinant Vaccines Consumption Market Share Forecast, by Application
Table Global Recombinant Vaccines Market Revenue (Million USD) Forecast, by Application
Table Global Recombinant Vaccines Revenue Market Share Forecast, by Application
Figure Global Recombinant Vaccines Consumption Value (Million USD) and Growth Rate of Recombinant Human Vaccines (2022-2027)
Figure Global Recombinant Vaccines Consumption Value (Million USD) and Growth Rate of Animal Recombinant Vaccines (2022-2027)
Figure Recombinant Vaccines Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Green Cross Corporation Profile
Table Green Cross Corporation Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Green Cross Corporation Recombinant Vaccines Sales Volume and Growth Rate
Figure Green Cross Corporation Revenue (Million USD) Market Share 2017-2022
Table Bayer AG Profile
Table Bayer AG Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bayer AG Recombinant Vaccines Sales Volume and Growth Rate
Figure Bayer AG Revenue (Million USD) Market Share 2017-2022
Table Mitsubishi Tanabe Pharma Corporation Profile
Table Mitsubishi Tanabe Pharma Corporation Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Mitsubishi Tanabe Pharma Corporation Recombinant Vaccines Sales Volume and Growth Rate
Figure Mitsubishi Tanabe Pharma Corporation Revenue (Million USD) Market Share 2017-2022
Table Pfizer, Inc. Profile
Table Pfizer, Inc. Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer, Inc. Recombinant Vaccines Sales Volume and Growth Rate
Figure Pfizer, Inc. Revenue (Million USD) Market Share 2017-2022
Table GlaxoSmithKline Profile
Table GlaxoSmithKline Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GlaxoSmithKline Recombinant Vaccines Sales Volume and Growth Rate
Figure GlaxoSmithKline Revenue (Million USD) Market Share 2017-2022
Table Protein Science Corporation Profile
Table Protein Science Corporation Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Protein Science Corporation Recombinant Vaccines Sales Volume and Growth Rate
Figure Protein Science Corporation Revenue (Million USD) Market Share 2017-2022
Table Merck & Co., Inc Profile
Table Merck & Co., Inc Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck & Co., Inc Recombinant Vaccines Sales Volume and Growth Rate
Figure Merck & Co., Inc Revenue (Million USD) Market Share 2017-2022
Table Sanofi Pasteur SA Profile
Table Sanofi Pasteur SA Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi Pasteur SA Recombinant Vaccines Sales Volume and Growth Rate
Figure Sanofi Pasteur SA Revenue (Million USD) Market Share 2017-2022
Table Daiichi Sankyo Profile
Table Daiichi Sankyo Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Daiichi Sankyo Recombinant Vaccines Sales Volume and Growth Rate
Figure Daiichi Sankyo Revenue (Million USD) Market Share 2017-2022
Table Serum Institute of India Pvt. Ltd Profile
Table Serum Institute of India Pvt. Ltd Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Serum Institute of India Pvt. Ltd Recombinant Vaccines Sales Volume and Growth Rate
Figure Serum Institute of India Pvt. Ltd Revenue (Million USD) Market Share 2017-2022
Table Pfizer Inc. Profile
Table Pfizer Inc. Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Inc. Recombinant Vaccines Sales Volume and Growth Rate
Figure Pfizer Inc. Revenue (Million USD) Market Share 2017-2022
Table Abiomed Profile
Table Abiomed Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Abiomed Recombinant Vaccines Sales Volume and Growth Rate
Figure Abiomed Revenue (Million USD) Market Share 2017-2022
Table Emergent Bio Solutions, Inc. Profile
Table Emergent Bio Solutions, Inc. Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Emergent Bio Solutions, Inc. Recombinant Vaccines Sales Volume and Growth Rate
Figure Emergent Bio Solutions, Inc. Revenue (Million USD) Market Share 2017-2022
Table Johnson & Johnson Profile
Table Johnson & Johnson Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Johnson & Johnson Recombinant Vaccines Sales Volume and Growth Rate
Figure Johnson & Johnson Revenue (Million USD) Market Share 2017-2022
Figure Recombinant Vaccines Product Picture
Table Global Recombinant Vaccines Market Sales Volume and CAGR (%) Comparison by Type
Table Recombinant Vaccines Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Recombinant Vaccines Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Recombinant Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Recombinant Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Recombinant Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Recombinant Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Recombinant Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Recombinant Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Recombinant Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Recombinant Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Recombinant Vaccines Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Recombinant Vaccines Industry Development
Table Global Recombinant Vaccines Sales Volume by Player (2017-2022)
Table Global Recombinant Vaccines Sales Volume Share by Player (2017-2022)
Figure Global Recombinant Vaccines Sales Volume Share by Player in 2021
Table Recombinant Vaccines Revenue (Million USD) by Player (2017-2022)
Table Recombinant Vaccines Revenue Market Share by Player (2017-2022)
Table Recombinant Vaccines Price by Player (2017-2022)
Table Recombinant Vaccines Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Recombinant Vaccines Sales Volume, Region Wise (2017-2022)
Table Global Recombinant Vaccines Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Recombinant Vaccines Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Recombinant Vaccines Sales Volume Market Share, Region Wise in 2021
Table Global Recombinant Vaccines Revenue (Million USD), Region Wise (2017-2022)
Table Global Recombinant Vaccines Revenue Market Share, Region Wise (2017-2022)
Figure Global Recombinant Vaccines Revenue Market Share, Region Wise (2017-2022)
Figure Global Recombinant Vaccines Revenue Market Share, Region Wise in 2021
Table Global Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Recombinant Vaccines Sales Volume by Type (2017-2022)
Table Global Recombinant Vaccines Sales Volume Market Share by Type (2017-2022)
Figure Global Recombinant Vaccines Sales Volume Market Share by Type in 2021
Table Global Recombinant Vaccines Revenue (Million USD) by Type (2017-2022)
Table Global Recombinant Vaccines Revenue Market Share by Type (2017-2022)
Figure Global Recombinant Vaccines Revenue Market Share by Type in 2021
Table Recombinant Vaccines Price by Type (2017-2022)
Figure Global Recombinant Vaccines Sales Volume and Growth Rate of Subunit Recombinant Vaccines (2017-2022)
Figure Global Recombinant Vaccines Revenue (Million USD) and Growth Rate of Subunit Recombinant Vaccines (2017-2022)
Figure Global Recombinant Vaccines Sales Volume and Growth Rate of Attenuated Recombinant Vaccines (2017-2022)
Figure Global Recombinant Vaccines Revenue (Million USD) and Growth Rate of Attenuated Recombinant Vaccines (2017-2022)
Figure Global Recombinant Vaccines Sales Volume and Growth Rate of Vector Recombinant Vaccines (2017-2022)
Figure Global Recombinant Vaccines Revenue (Million USD) and Growth Rate of Vector Recombinant Vaccines (2017-2022)
Table Global Recombinant Vaccines Consumption by Application (2017-2022)
Table Global Recombinant Vaccines Consumption Market Share by Application (2017-2022)
Table Global Recombinant Vaccines Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Recombinant Vaccines Consumption Revenue Market Share by Application (2017-2022)
Table Global Recombinant Vaccines Consumption and Growth Rate of Recombinant Human Vaccines (2017-2022)
Table Global Recombinant Vaccines Consumption and Growth Rate of Animal Recombinant Vaccines (2017-2022)
Figure Global Recombinant Vaccines Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Recombinant Vaccines Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Recombinant Vaccines Price and Trend Forecast (2022-2027)
Figure USA Recombinant Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Recombinant Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Recombinant Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Recombinant Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Recombinant Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Recombinant Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Recombinant Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Recombinant Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Recombinant Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Recombinant Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Recombinant Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Recombinant Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Recombinant Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Recombinant Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Recombinant Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Recombinant Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Recombinant Vaccines Market Sales Volume Forecast, by Type
Table Global Recombinant Vaccines Sales Volume Market Share Forecast, by Type
Table Global Recombinant Vaccines Market Revenue (Million USD) Forecast, by Type
Table Global Recombinant Vaccines Revenue Market Share Forecast, by Type
Table Global Recombinant Vaccines Price Forecast, by Type
Figure Global Recombinant Vaccines Revenue (Million USD) and Growth Rate of Subunit Recombinant Vaccines (2022-2027)
Figure Global Recombinant Vaccines Revenue (Million USD) and Growth Rate of Subunit Recombinant Vaccines (2022-2027)
Figure Global Recombinant Vaccines Revenue (Million USD) and Growth Rate of Attenuated Recombinant Vaccines (2022-2027)
Figure Global Recombinant Vaccines Revenue (Million USD) and Growth Rate of Attenuated Recombinant Vaccines (2022-2027)
Figure Global Recombinant Vaccines Revenue (Million USD) and Growth Rate of Vector Recombinant Vaccines (2022-2027)
Figure Global Recombinant Vaccines Revenue (Million USD) and Growth Rate of Vector Recombinant Vaccines (2022-2027)
Table Global Recombinant Vaccines Market Consumption Forecast, by Application
Table Global Recombinant Vaccines Consumption Market Share Forecast, by Application
Table Global Recombinant Vaccines Market Revenue (Million USD) Forecast, by Application
Table Global Recombinant Vaccines Revenue Market Share Forecast, by Application
Figure Global Recombinant Vaccines Consumption Value (Million USD) and Growth Rate of Recombinant Human Vaccines (2022-2027)
Figure Global Recombinant Vaccines Consumption Value (Million USD) and Growth Rate of Animal Recombinant Vaccines (2022-2027)
Figure Recombinant Vaccines Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Green Cross Corporation Profile
Table Green Cross Corporation Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Green Cross Corporation Recombinant Vaccines Sales Volume and Growth Rate
Figure Green Cross Corporation Revenue (Million USD) Market Share 2017-2022
Table Bayer AG Profile
Table Bayer AG Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bayer AG Recombinant Vaccines Sales Volume and Growth Rate
Figure Bayer AG Revenue (Million USD) Market Share 2017-2022
Table Mitsubishi Tanabe Pharma Corporation Profile
Table Mitsubishi Tanabe Pharma Corporation Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Mitsubishi Tanabe Pharma Corporation Recombinant Vaccines Sales Volume and Growth Rate
Figure Mitsubishi Tanabe Pharma Corporation Revenue (Million USD) Market Share 2017-2022
Table Pfizer, Inc. Profile
Table Pfizer, Inc. Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer, Inc. Recombinant Vaccines Sales Volume and Growth Rate
Figure Pfizer, Inc. Revenue (Million USD) Market Share 2017-2022
Table GlaxoSmithKline Profile
Table GlaxoSmithKline Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GlaxoSmithKline Recombinant Vaccines Sales Volume and Growth Rate
Figure GlaxoSmithKline Revenue (Million USD) Market Share 2017-2022
Table Protein Science Corporation Profile
Table Protein Science Corporation Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Protein Science Corporation Recombinant Vaccines Sales Volume and Growth Rate
Figure Protein Science Corporation Revenue (Million USD) Market Share 2017-2022
Table Merck & Co., Inc Profile
Table Merck & Co., Inc Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck & Co., Inc Recombinant Vaccines Sales Volume and Growth Rate
Figure Merck & Co., Inc Revenue (Million USD) Market Share 2017-2022
Table Sanofi Pasteur SA Profile
Table Sanofi Pasteur SA Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi Pasteur SA Recombinant Vaccines Sales Volume and Growth Rate
Figure Sanofi Pasteur SA Revenue (Million USD) Market Share 2017-2022
Table Daiichi Sankyo Profile
Table Daiichi Sankyo Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Daiichi Sankyo Recombinant Vaccines Sales Volume and Growth Rate
Figure Daiichi Sankyo Revenue (Million USD) Market Share 2017-2022
Table Serum Institute of India Pvt. Ltd Profile
Table Serum Institute of India Pvt. Ltd Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Serum Institute of India Pvt. Ltd Recombinant Vaccines Sales Volume and Growth Rate
Figure Serum Institute of India Pvt. Ltd Revenue (Million USD) Market Share 2017-2022
Table Pfizer Inc. Profile
Table Pfizer Inc. Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Inc. Recombinant Vaccines Sales Volume and Growth Rate
Figure Pfizer Inc. Revenue (Million USD) Market Share 2017-2022
Table Abiomed Profile
Table Abiomed Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Abiomed Recombinant Vaccines Sales Volume and Growth Rate
Figure Abiomed Revenue (Million USD) Market Share 2017-2022
Table Emergent Bio Solutions, Inc. Profile
Table Emergent Bio Solutions, Inc. Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Emergent Bio Solutions, Inc. Recombinant Vaccines Sales Volume and Growth Rate
Figure Emergent Bio Solutions, Inc. Revenue (Million USD) Market Share 2017-2022
Table Johnson & Johnson Profile
Table Johnson & Johnson Recombinant Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Johnson & Johnson Recombinant Vaccines Sales Volume and Growth Rate
Figure Johnson & Johnson Revenue (Million USD) Market Share 2017-2022
